NSG 533 Exam 3 Study Set Exam
Questions All Solved.
symptoms of uncontrolled asthma - Answer at least three of the following:
-daytime asthma more than 2x a week
-nighttime awakening
-reliever therapy more than 2x a week
-activity intolerance
treatment of asthma symptoms less than 2x a month - Answer as needed low dose ICS-formoterol or as
needed low dose ICS with SABA
treatment of asthma symptoms more than 2x a month - Answer daily low dose ICS and as needed
SABA or as needed low dose ICS-formoterol
treatment of asthma symptoms most days of the week - Answer daily low dose ICS-formoterol and as
needed SABA or daily medium dose ICS and SABA
treatment of daily asthma symptoms (severe asthma) - Answer daily medium dose ICS-formoterol with
reliever therpy OR daily high dose ICS with reliever therapy
ICS-formoterol medication drug name - Answer budesonide-formoterol
Short-acting muscarinic antagonist (SAMA) - Answer Ipratropium
avoid co administration of ICS with which CYP3A4 inhibitors? (may cause cushing's) - Answer ritonavir,
itraconazole, ketoconazole
lack of response to ICS may be indicative of what? - Answer CLCCl1 gene
, LABAs - Answer Salmeterol
Formoterol
Vilanterol
LAMAs - Answer tiotropium bromide
umeclidinium
lueokotriene receptor antagonists - Answer -lukast
monoclonal antibodies - Answer -umab, monitor for adverse events 2 hours afterwards for 3 months
and then 30 minutes afterwards therafter, co-prescribe with epipen
contraindications for theophylline (methylxanthine) - Answer pulmonary edema, hypothyroidism, liver
disease, renal dysfunction, recent smoking cessation, pregnancy, antifungal agents, carbamazepine,
rifampin, etc.
which beta blockers are contraindicated in asthma - Answer nadolol, propranolol, timolol, sotaolol
COPD classification A (few symptoms, low exposure risk) - Answer SABA
COPD classification B (more symptoms, low exacerbation risk) - Answer LABA or LAMA
COPD classification C (few symptoms, high exacerbation risk) - Answer LAMA
COPD classification D (more symptoms, high exacerbation risk) - Answer LAMA or LAMA+LABA or ICS-
LABA
Roflumilast - Answer phosphodiesterase-4 inhibitor, may cause weight loss, diarrhea, and depression
Intranasal decongestants - Answer oxymetazoline, phenylephrine, naphazoline
Questions All Solved.
symptoms of uncontrolled asthma - Answer at least three of the following:
-daytime asthma more than 2x a week
-nighttime awakening
-reliever therapy more than 2x a week
-activity intolerance
treatment of asthma symptoms less than 2x a month - Answer as needed low dose ICS-formoterol or as
needed low dose ICS with SABA
treatment of asthma symptoms more than 2x a month - Answer daily low dose ICS and as needed
SABA or as needed low dose ICS-formoterol
treatment of asthma symptoms most days of the week - Answer daily low dose ICS-formoterol and as
needed SABA or daily medium dose ICS and SABA
treatment of daily asthma symptoms (severe asthma) - Answer daily medium dose ICS-formoterol with
reliever therpy OR daily high dose ICS with reliever therapy
ICS-formoterol medication drug name - Answer budesonide-formoterol
Short-acting muscarinic antagonist (SAMA) - Answer Ipratropium
avoid co administration of ICS with which CYP3A4 inhibitors? (may cause cushing's) - Answer ritonavir,
itraconazole, ketoconazole
lack of response to ICS may be indicative of what? - Answer CLCCl1 gene
, LABAs - Answer Salmeterol
Formoterol
Vilanterol
LAMAs - Answer tiotropium bromide
umeclidinium
lueokotriene receptor antagonists - Answer -lukast
monoclonal antibodies - Answer -umab, monitor for adverse events 2 hours afterwards for 3 months
and then 30 minutes afterwards therafter, co-prescribe with epipen
contraindications for theophylline (methylxanthine) - Answer pulmonary edema, hypothyroidism, liver
disease, renal dysfunction, recent smoking cessation, pregnancy, antifungal agents, carbamazepine,
rifampin, etc.
which beta blockers are contraindicated in asthma - Answer nadolol, propranolol, timolol, sotaolol
COPD classification A (few symptoms, low exposure risk) - Answer SABA
COPD classification B (more symptoms, low exacerbation risk) - Answer LABA or LAMA
COPD classification C (few symptoms, high exacerbation risk) - Answer LAMA
COPD classification D (more symptoms, high exacerbation risk) - Answer LAMA or LAMA+LABA or ICS-
LABA
Roflumilast - Answer phosphodiesterase-4 inhibitor, may cause weight loss, diarrhea, and depression
Intranasal decongestants - Answer oxymetazoline, phenylephrine, naphazoline
